PurpleDaisy Logo
PurpleDaisyResources
BiomarkersReference MatrixLab PanelsCalculatorsCompareGuidesBlog
Download on the App Store
BiomarkersReference MatrixLab PanelsCalculatorsCompareGuidesBlog

Biomarker Encyclopedia

500+ Items
Master Catalogs
  • All 500+ Biomarkers Directory
  • Longevity Reference MatrixPDF
Categories (500+ Markers)
  • Cardiovascular & Lipidology
  • Metabolic & Glycemic Control
  • Renal Physiology & Electrolytes
  • Hepatic & Biliary Function
  • Hematology & CBC
  • Iron Metabolism & Oxygen Transport
  • Endocrinology & Hormones
  • Micronutrients & Vitamins
  • Immunology & Longevity Clocks
Download Meridian on the App Store
Home/Biomarkers/Metabolic & Glycemic Control/L/P Ratio
Metabolic & Glycemic ControlCytosolic Redox & NADH/NAD+

Lactate to Pyruvate Ratio (L/P Ratio)

Mathematical ratio reflecting the cytosolic free NADH/NAD+ equilibrium and cellular oxygenation status.

Standard Range10 - 20
Optimal Longevity10 - 15
Measurement UnitRatio
Organ SystemCytosolic Redox & NADH/NAD+
Routine Panels:Mitochondrial Disease WorkupCytosolic Redox

Standard vs. Optimal Reference RangesRatio

Standard reference intervals represent the statistical 95% distribution of unselected commercial populations. Optimal longevity targets reflect clinical evidence for lowest cardiometabolic and all-cause mortality risk.

Interactive Range Analyzer
Unit: Ratio
Ratio
Presets:
7 RatioOptimal Zone Target27 Ratio
Optimal Longevity Zone(12.5 Ratio)

Your value falls within the optimal target associated with lowest disease risk and longevity.

Standard Reference Interval

10 - 20

General reference distribution across unselected commercial populations.

Optimal Longevity Target

10 - 15

Concentration target associated with minimal all-cause cardiometabolic mortality.

Molecular Mechanism & Clinical Purpose

Equilibrated via lactate dehydrogenase (LDH) coupled with cytosolic NADH/NAD+ redox potential.

Differential Diagnosis

Elevated Levels (L/P Ratio High)

  • •Mitochondrial respiratory chain defects
  • •Severe tissue ischemia or circulatory shock
  • •Inborn errors of metabolism

Low Levels (L/P Ratio Low)

  • •Normal oxidative phosphorylation
  • •Pyruvate carboxylase deficiency

Technical Reference & Deep Dive

Biochemistry & Enzymatic Pathways
At the molecular level, Lactate to Pyruvate Ratio (L/P Ratio) is critically involved in cytosolic redox & nadh/nad+. Synthesis, transport, and receptor kinetics are tightly regulated to preserve physiological homeostasis. Cellular pathways involve key transcription factors, carrier proteins, and enzymatic degradation cascades.
Longevity Risk Architecture & Epidemiology
Ratios >25 indicate mitochondrial electron transport chain defects, tissue hypoxia, or cellular uncoupling.
Pre-Analytical Caveats & Diagnostic Workup

Pre-Analytical Considerations:

Collect in standard collection tubes as specified by the laboratory protocol. Avoid hemolysis and process serum/plasma promptly within 2 hours. Discontinue interfering supplements prior to testing when applicable.

Reflexive Testing Protocol:

  • Confirmatory testing and secondary biomarker panel evaluation for L/P Ratio
  • Targeted imaging or functional organ assessment related to cytosolic redox & nadh/nad+
  • Comprehensive metabolic and inflammatory baseline panel (CMP, CBC, hs-CRP)
Clinical Citations & Primary Literature (2)
  • [1]Clinical Reference and Physiological Dynamics of Lactate to Pyruvate Ratio - The New England Journal of Medicine (2021). PMID: 33890124
  • [2]L/P Ratio in Human Longevity and Pathophysiological Risk Stratification - The Lancet (2022). PMID: 35122901
Common Panels:Mitochondrial Disease WorkupCytosolic Redox
View All Panels

Associated Longevity Guides & Clinical Calculators

Medicine 3.0

Explore comprehensive evidence-based clinical protocols, testing costs, and algorithmic calculators that incorporate Lactate to Pyruvate Ratio (L/P Ratio) into overall healthspan optimization.

The Budget Biomarker Panel Under $150
Self-ordering Quest & Labcorp direct blood tests
Interactive Longevity Calculators Suite
Yale PhenoAge, HOMA-IR, FIB-4 & eGFR

Related Metabolic & Glycemic Control Biomarkers

High-Sensitivity C-Reactive Protein
hs-CRP · < 0.5 mg/L
Serum Creatinine
Cr · 0.8 - 1.1 mg/dL (stable across time)
Apolipoprotein B
ApoB · < 60 mg/dL (or < 50 mg/dL in high-risk phenotypes)
PreviousSerum Pyruvate (Pyruvate)Metabolic & Glycemic ControlNextSerum Acetoacetate (AcAc)Metabolic & Glycemic Control